FDA Approves New Abortion Drug
By Susan Brinkmann, OCDS
Staff Journalist
The Food and Drug Administration (FDA) has approved the use of Ella, a drug currently being marketed in Europe as a "morning after pill", even though it has not undergone rigorous testing in the U.S. and has been known to cause birth defects in children who survived after their mothers used the drug.
